This article explores 10 new regenerative medicine solutions shaping the healthcare industry. They offer skeletal muscle tissue regeneration, body part restoration, and more. These companies also focus on age-related health improvements, new treatments for osteoporosis, and advanced tumor immunotherapy. Each company thus contributes distinctively to enhance patient outcomes. This report was last updated 5 days ago. Spot an error or missing detail? Help us fix it by getting in touch!
Continue reading to gain up-to-date and data-driven insights on:
- Profiles of 10 Emerging Regenerative Medicine Solutions
- How to Scout New Regenerative Medicine Solutions Easily
Click to download
Key Takeaways
Drawing insights from the Big Data & AI-powered StartUs Insights Discovery Platform that provides data on over 4.7+ million emerging companies globally, we explore the evolving landscape of the regenerative medicine industry. This sector is marked by key trends and a substantial workforce, shaping its future. Here are some key insights at a glance:
- Latest Regenerative Medicine Trends: Some of the major trends impacting the regenerative medicine industry are advanced gene editing, tissue engineering, stem cell therapeutics, and bio-based materials.
- Regenerative Medicine Industry Stats: The global regenerative medicine industry encompasses 3.4K+ organizations and has a massive 150.1k workforce. It is experiencing a rise of 4.05% in annual growth rate and has seen the emergence of 1.2K + new regenerative medicine companies in the past five years. On average, each of these new companies employs about 15 people.
- 10 New Regenerative Medicine Solutions to Watch:
- InGel Therapeutics – Cellular Development Platform
- Conexeu Sciences – Liquid Skin Substitute
- TherageniX – Tissue Regeneration
- MUVON Therapeutics – Skeletal Muscle Tissue Regeneration
- Nayacure Labs – Personalized Organs
- Orchard Bio – Drug-encapsulated PLGA Nanoparticles
- Acasta Health – Longevity Medicine
- Moroxite F – Fracture Fixation
- iCamuno Biotherapeutics – Tumor Immunotherapy
- Karis Bio – Cell-Based Therapy
Discover 10 out of 1.2K+ Emerging Regenerative Medicine Solutions
In this section, we highlight 10 top regenerative medicine companies innovating in skeletal muscle tissue regeneration, organ restoration, and more. By utilizing the latest tools in biotechnology, these companies achieve precise therapeutic outcomes, improve patient care, and extend the possibilities in healthcare.
Note on Signal Strength
One of the unique metrics we feature for each company is Signal Strength, a proprietary data point generated by our Discovery Platform. It gauges the extent to which a company’s influence has permeated the global ecosystem of startups, scaleups, and emerging companies. This proprietary metric serves as a valuable guidepost for understanding a company’s standing in the broader market landscape.
1. InGel Therapeutics
- Founding Year: 2021
- Employee Range: 2-10
- Location: USA
- Signal Strength: Very Strong
- What they do: InGel Therapeutics leverages engineered cell therapy to target neuroprotective pathways. The company identified a cell state, Precursor Cells, for retinal neurons during the cell differentiation process. They have high purity while being proliferative and address the issue of undetermined cell fate and uncontrolled cell-cell interactions in traditional stem cell therapies. The company also develops a biomimetic hydrogel matrix for delivering retinal neurons in vivo. Mimicking the human vitreous, this hydrogel facilitates intravitreal and subretinal injections to optimize stiffness and degradation timelines for precise delivery. It combats retinal degenerative diseases like retinitis pigmentosa.
2. Conexeu Sciences
- Founding Year: 2022
- Employee Range: 2-10
- Location: Canada
- Signal Strength: Medium Strong
- What they do: Conexeu Sciences makes regenerative aesthetics and wound care products for skin restoration. This includes applications for wound care such as burns, acute wounds, and diabetic ulcers, as well as aesthetic uses for soft tissue fillers. The company’s Ten-Minute-Tissue is a liquid skin substitute that gels within 10 minutes after application. This promotes faster wound healing and better epithelialization, improving cell survival and reducing inflammation. Consequently, it supports natural healing and integrates easily with patient cells.
3. TherageniX
- Founding Year: 2022
- Employee Range: 0-1
- Location: UK
- Signal Strength: Very Strong
- What they do: TherageniX offers a gene therapy for tissue regeneration. The company uses a proprietary non-viral delivery system to instruct the body to produce proteins that aid tissue regeneration for orthopedic applications. TherageniX offers genes like vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP) to improve autologous bone grafts intra-operatively. The process integrates autologous bone marrow cells and autograft materials during surgery to enhance regenerative capacity and functional outcomes while reducing trauma.
4. MUVON Therapeutics
- Founding Year: 2020
- Employee Range: 11-50
- Location: Switzerland
- Signal Strength: Very Strong
- What they do: MUVON Therapeutics develops a regenerative therapy platform for skeletal muscle tissue regeneration. Its autologous cell therapy repairs damaged tissue and also enhances the regenerative potential of weakened muscles. The company also isolates muscle precursor cells from a small muscle biopsy under local anesthesia. These cells undergo controlled expansion and quality testing before being injected into the patient’s muscle to initiate regeneration and connection with existing tissue. MUVON Therapeutics primarily targets the treatment of stress urinary incontinence (SUI) in women by offering a minimally invasive, low-risk option.
5. Nayacure Labs
- Founding Year: 2020
- Employee Range: 2-10
- Location: Israel
- Signal Strength: Strong
- What they do: Nayacure Labs creates human-compatible organs to restore the function of failing bodies. It replaces the innermost layer of donor blood vessels with non-immunogenic, placental cells. Additionally, the company overcomes the immunological barriers to xenotransplantation. This provides a sustainable source of humanized organs, addresses critical shortages in organ transplantation, and reduces dependence on immunosuppressive medications.
6. Orchard Bio
- Founding Year: 2021
- Employee Range: 2-10
- Location: Japan
- Signal Strength: Medium Strong
- What they do: Orchard Bio develops hAP cell, a hybrid regenerative medicine product that combines conventional pharmaceuticals with living cells. It leverages a biodegradable polymer and poly-lactide-co-glycolide acid (PLGA) to encapsulate the active pharmaceutical ingredient. Once administered, hAP cells target injury sites by leveraging their intrinsic cellular functions to accumulate and gradually release the encapsulated drug, improving tissue regeneration.
7. Acasta Health
- Founding Year: 2020
- Employee Range: 2-10
- Location: India
- Signal Strength: Medium Strong
- What they do: Acasta Health offers therapeutics for aging and associated conditions. Its Acasta Age-MAP platform for biological age assessment provides insights into a patient’s energy levels, disease risk factors, and biological age. For this, the platform uses genomic, proteomic, metabolomic, clinical, and functional biomarkers. The platform aligns sports, health, and wellness programs with their real biological age, supporting individuals in managing their health more proactively. Patients use this targeted and personalized approach to reduce age-related degenerative diseases.
8. Moroxite F
- Founding Year: 2020
- Employee Range: 1-10
- Location: Sweden
- Signal Strength: Very Strong
- What they do: Moroxite F enhances implant anchorage for osteoporosis. It develops a fracture anchorage and regeneration method by combining surgical techniques, biomaterials, and drug delivery systems. This approach improves screw-bone anchorage by injecting a ceramic nano-material into the interface between the metallic screw and adjacent fragile osteoporotic bone. The company’s implant anchorage activates particulate hydroxyapatite with bisphosphonates which targets bone regeneration. This stimulates new bone formation and reduces the risk of fixation failure and the need for reoperation.
9. iCamuno Biotherapeutics
- Founding Year: 2021
- Employee Range: 51-100
- Location: China
- Signal Strength: Strong
- What they do: iCamuno Biotherapeutics provides iCam-iPSC, a super-potent stem cell platform. It produces induced pluripotent stem cells (iPSCs) with an epigenome resembling human embryonic stem cells. The platform also develops targeted solutions through its iCam-intelligent engineering platform. It improves the effectiveness of tumor immune cell therapies to increase gene editing precision and efficiency. Further, this platform integrates computer biology algorithms with single-cell multi-omics analysis to optimize the production of tumor immune cells and regenerative medicine-related cells, such as mesenchymal stem cells and cardiomyocytes.
10. Karis Bio
- Founding Year: 2020
- Employee Range: 1-10
- Location: South Korea
- Signal Strength: Very Strong
- What they do: Karis Bio treats cardiovascular diseases through its hiPSC-EC technology. The company’s human-induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) form new blood vessels and improve vascular health in patients. Karis Bio also utilizes a virus-free, xenogeneic ingredient-free method for generating hiPSCs and differentiating them into highly purified functional endothelial cells. This technology supports treatments for conditions like peripheral arterial disease (PAD) and critical limb ischemia (CLI) while reducing production costs.
Quick Tip to Find New Regenerative Medicine Solutions
Utilizing a SaaS platform like the Discovery Platform for identifying new regenerative medicine solutions provides significant benefits compared to traditional scouting methods:
- Streamlined Efficiency: The Discovery Platform offers advanced tools that streamline the scouting process. It replaces your hours of conventional desk research, saving time and resources in identifying regenerative medicine innovations.
- Access to Real-time Insights: Gain a competitive edge with up-to-date information on the latest trends in the regenerative medicine industry. The platform keeps you informed with near real-time updates on emerging regenerative medicine solutions and news, enabling you to make swift and informed decisions.
- Precise Scouting: Customize your search to focus on specific niches within the regenerative medicine sector, such as tissue regeneration via gene therapy, skeletal muscle tissue regeneration, or personalized organs. The platform’s diverse filtering options allow you to target your scouting efforts precisely, ensuring that you find the most relevant and groundbreaking companies in the field.
Ready to Explore All New Regenerative Medicine Solutions?
This overview highlights just a few regenerative medicine solutions from all 1.2K+ new companies currently covered by the Discovery Platform. To explore them all, book a personalized demo or download one of our free Industry Innovation Reports for a quick overview. Interested in enhancing our coverage of startups and tech? We value insights from experts like you – reach out!
